Loading...
Loading...
BNTC| Name | Value |
|---|---|
| Revenues | 54.0K |
| Cost of Revenue | 32.0K |
| Gross Profit | 22.0K |
| Operating Expense | 4,395.0K |
| Operating I/L | -4,341.0K |
| Other Income/Expense | -56.0K |
| Interest Income | 10.5K |
| Pretax | -4,397.0K |
| Income Tax Expense | 63.0K |
| Net Income/Loss | -4,460.0K |
Benitec Biopharma Inc. is a biotechnology company specializing in the development of DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. The company's main focus is on developing gene therapy agents such as BB-301 for treating oculopharyngeal muscular dystrophy and BB-103 for chronic hepatitis B virus infection.
